Heparin resistance in relation to hyperlipidemia and hypercoagulability in atherosclerotic diabetics and non-diabetics.
D000328:Adult; D001161:Arteriosclerosis / Q000188:drug therapy; D001772:Blood Cell Count; D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D001780:Blood Coagulation Tests; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy; D048909:Diabetes Complications; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D004351:Drug Resistance; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications*; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D008055:Lipids / Q000097:blood; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D013927:Thrombosis / Q000188:drug therapy
D008055:Lipids; D006493:Heparin